Tumor necrotic factor as an inhibitor of angiogenesis
Sopotsinskaia, E.B.; Lisniak, I.A.
Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 5: 62-64
1988
ISSN/ISBN: 0031-2991 PMID: 2464155 Document Number: 319878
Document emailed within 1 workday
Related Documents
Yamaguchi, K.; Ogawa, K.; Katsube, T.; Shimao, K.; Konno, S.; Shimakawa, T.; Yoshimatsu, K.; Naritaka, Y.; Yagawa, H.; Hirose, K. 2005: Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis Anticancer Research 25(2a): 847-851Zarrouk, K. 1978: The tumor angiogenesis factor (TAF) Archives de l'Institut Pasteur de Tunis 55(3): 247-273
2002: The angiogenesis inhibitor vasostatin. In tumor inhibiting doses there is no impaired wound healing in the mouse model Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 53(2): 154
Locigno, R.; Antoine, N.; Bours, V.; Daukandt, M.; Heinen, E.; Castronovo, V. 2000: TNP-470, a potent angiogenesis inhibitor, amplifies human T lymphocyte activation through an induction of nuclear factor-kappaB, nuclear factor-AT, and activation protein-1 transcription factors Laboratory Investigation; A Journal of Technical Methods and Pathology 80(1): 13-21
Senger, D.R.; Brown, L.F.; Claffey, K.P.; Dvorak, H.F. 1994: Vascular permeability factor, tumor angiogenesis and stroma generation Invasion and Metastasis 14(1-6): 385-394
Beyaert, R.; Vanhaesebroeck, B.; Heyninck, K.; Boone, E.; De Valck, D.; Schulze-Osthoff, K.; Haegeman, G.; Van Roy, F.; Fiers, W. 1993: Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine Cancer Research 53(11): 2623-2630
Sun, W.; Jiang, Z.; Xiang, T.-X.; Tao, X.-H.; Huang, A.-L.; Wang, P.-L. 2009: Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice Zhonghua Yi Xue Za Zhi 89(12): 841-845
Claffey, K.P.; Brown, L.F.; del Aguila, L.F.; Tognazzi, K.; Yeo, K.T.; Manseau, E.J.; Dvorak, H.F. 1996: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Research 56(1): 172-181
Werther, K.; Nielsen, H.J. 2000: Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors Ugeskrift for Laeger 162(37): 4916-4920
Heng, M.C.; Harker, J.; Csathy, G.; Marshall, C.; Brazier, J.; Sumampong, S.; Paterno Gomez, E. 2000: Angiogenesis in necrotic ulcers treated with hyperbaric oxygen Ostomy/Wound Management 46(9): 18-28; 30-32
Yin, P.; Qiu, X.-f.; Liu, Z.-c. 2005: Expression of inductive nitric oxide synthase and vascular endothelial growth factor in colonic carcinoma, and their effects on tumor angiogenesis Zhonghua Wei Chang Wai Ke Za Zhi 8(6): 513-515
Miszczak-Zaborska, E.; Smolarek, M.; Bartkowiak, J. 2010: Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors Postepy Biochemii 56(1): 61-66
Ono, M.; Kuwano, M. 2001: Tumor angiogenesis and tumor angiogenesis inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(5): 584-590
Hu, Z.L.; Qian, D.H. 1993: Effects of protein kinase C activator and inhibitor on release of tumor necrosis factor from mouse peritoneal macrophages Zhongguo Yao Li Xue Bao 14(2): 183-186
Wu, J.J.; Poon, K-Yee.T.; Bebchuk, J.D. 2013: Association between the type and length of tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis Journal of drugs in dermatology: JDD 12(8): 899-903
Maydick-Youngberg, D. 2001: Angiogenesis in necrotic ulcers treated with hyperbaric oxygen--comparing apples with apples Ostomy/Wound Management 47(3): 8
Kotyla, P.J.; Sliwinska-Kotyla, B.; Kucharz, E.J. 2006: Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin Journal of rheumatology 33(11): 2361-3; author reply 2363
Scuderi, P. 1989: Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME) Journal of Immunology 143(1): 168-173
Hoekman, K. 2001: SU6668, a multitargeted angiogenesis inhibitor Cancer Journal 7(Suppl 3): S134-S138
Yi, W.-Q.; Gan, H.-T.; Huang, X.-L.; Zhang, M.; Ouyang, Q. 2007: The effects of p38 mitogen activated protein kinase inhibitor SB203580 on colonic mucosa tumor necrosis factor alpha expression in ulcerative colitis Zhonghua Nei Ke Za Zhi 46(9): 747-750